Vala Sciences provides high‑content kinetic screening tools that convert cellular signals into dynamic, actionable data for drug discovery and disease modeling. Their platform includes the KIC® kinetic image cytometer, CyteSeer® single‑cell analysis software, and ValaSIM™ 3D imaging, enabling researchers to capture precise effects of drug treatments at the single‑cell level.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional cell-based assays often provide only static, endpoint measurements, limiting the ability to capture dynamic cellular responses and subtle phenotypic changes that are critical for drug discovery and disease modeling.
Solution
Vala Sciences offers high‑content kinetic screening platforms that record live cellular signals over time, converting them into quantitative, single‑cell data. The IC200 Kinetic Image Cytometer (KIC®) delivers high‑resolution, time‑resolved imaging with single‑cell precision, while CyteSeer® software performs advanced analysis of cellular dynamics and phenotypic trajectories. ValaSIM™ adds low‑phototoxicity 3D imaging for complex structures such as organoids, enabling comprehensive assessment of morphology and function. Together, these tools provide researchers with dynamic, actionable insights for preclinical efficacy, safety, and mechanistic studies across drug discovery, cardiac safety, and neuroscience applications.
Target Audience
Primary customers are pharmaceutical and biotech researchers conducting preclinical drug discovery, safety pharmacology, and disease‑modeling studies, particularly those needing high‑content, kinetic data from 2D and 3D cell systems.
Features
- IC200 KIC® kinetic image cytometer captures time‑resolved, high‑content images at single‑cell resolution
- CyteSeer® software delivers advanced single‑cell trajectory analysis and kinetic phenotyping
- ValaSIM™ provides high‑resolution 3D imaging with minimal phototoxicity for organoids and 3D cultures
- Integrated workflow supports high‑throughput screening and longitudinal studies
- Enables contract research services for cardiac safety (ValaDATE.AI™ with prophECG™) and neuroscience modeling